Mycophenolate Mofetil Tablets I.P. (CellCept)
₦0.00
Mycophenolate Mofetil Tablets I.P. (CellCept) are prescription immunosuppressant tablets used to prevent organ rejection in kidney, heart, and liver transplant patients. Each tablet contains Mycophenolate Mofetil, which helps your body accept a new organ by reducing immune system activity. Manufactured by Roche, CellCept is clinically proven, trusted by specialists worldwide, and available in 250 mg and 500 mg strengths. Keywords: Mycophenolate Mofetil tablets, CellCept 500 mg price in Nigeria, immunosuppressant for transplant, anti-rejection medicine, Roche CellCept
Share:
Long Description (SEO-Optimized)
Mycophenolate Mofetil Tablets I.P. (CellCept) are a leading immunosuppressive medication formulated to help prevent your body from rejecting a transplanted kidney, heart, or liver. Each tablet contains the active ingredient Mycophenolate Mofetil, which converts into mycophenolic acid in the body — a potent inhibitor of lymphocyte proliferation.
By selectively blocking the enzyme inosine monophosphate dehydrogenase (IMPDH), CellCept reduces the production of DNA in T and B lymphocytes, the key cells responsible for immune rejection. This targeted mechanism makes it highly effective in organ transplant maintenance therapy when used alongside corticosteroids and cyclosporine.